PERSPECTA

News from every angle

Back to headlines

AstraZeneca Advances Weight-Loss Pill Development

AstraZeneca is progressing with its weight-loss pill, aiming to compete with market leaders Novo Nordisk and Eli Lilly in the obesity treatment sector.

8 Jun, 20:15 — 8 Jun, 20:15
PostShare